Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106360 · ClinicalTrials.gov registry record
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
A clinical trial of Solid Tumor and Hematological Malignancy, sponsored by Inova Health Care Services.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06106360: Recruiting study of Solid Tumor and Hematological Malignancy, sponsored by Inova Health Care Services.
NCT06106360 is a study of Solid Tumor and Hematological Malignancy that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 100 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06106360, a study of Solid Tumor and Hematological Malignancy, is actively recruiting participants, sponsored by Inova Health Care Services.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.
Primary Outcome
The feasibility is determined when 80% of the patients wear the watch at least 70% of the time during waking hours.
Conditions Studied
Interventions
- DEVICE Locus Health iPhone App
Study Locations (1)
Virginia
- Inova Schar Cancer Institute - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-26 |
| Est. Completion | 2026-06-26 |
What NCT06106360 shows while recruiting
NCT06106360 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (55% lower).
The record links to 2 conditions, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Locus Health iPhone App is the first listed.
NCT06106360 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06106360 about?
NCT06106360 is a clinical study titled "A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy". A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.
What is the current status of trial NCT06106360?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-10-26. Estimated completion is 2026-06-26.
What conditions does trial NCT06106360 study?
This clinical trial studies the following conditions: Solid Tumor, Hematological Malignancy.
What interventions are being tested in trial NCT06106360?
The interventions under investigation include: Locus Health iPhone App (DEVICE).
Who is sponsoring clinical trial NCT06106360?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106360 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06106360's enrollment target sits among peer trials
100 85th of 196 higher than 108 of 196 other Solid Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI